196 related articles for article (PubMed ID: 33414540)
1. Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial).
Ueno H; Ishiguro M; Nakatani E; Ishikawa T; Uetake H; Murotani K; Matsui S; Teramukai S; Sugai T; Ajioka Y; Maruo H; Kotaka M; Tsujie M; Munemoto Y; Yamaguchi T; Kuroda H; Fukunaga M; Tomita N; Sugihara K
Br J Cancer; 2021 Mar; 124(6):1088-1097. PubMed ID: 33414540
[TBL] [Abstract][Full Text] [Related]
2. A Multicenter Study of the Prognostic Value of Desmoplastic Reaction Categorization in Stage II Colorectal Cancer.
Ueno H; Kanemitsu Y; Sekine S; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Kajiwara Y; Okamoto K; Mochizuki S; Tsujimoto H; Shinto E
Am J Surg Pathol; 2019 Aug; 43(8):1015-1022. PubMed ID: 31094924
[TBL] [Abstract][Full Text] [Related]
3. Desmoplastic Pattern at the Tumor Front Defines Poor-prognosis Subtypes of Colorectal Cancer.
Ueno H; Kanemitsu Y; Sekine S; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Mochizuki S; Kajiwara Y; Shinto E; Yamamoto J
Am J Surg Pathol; 2017 Nov; 41(11):1506-1512. PubMed ID: 28877064
[TBL] [Abstract][Full Text] [Related]
4. Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial.
Ueno H; Ishiguro M; Nakatani E; Ishikawa T; Uetake H; Matsuda C; Nakamoto Y; Kotake M; Kurachi K; Egawa T; Yasumasa K; Murata K; Ikawa O; Shinji S; Murotani K; Matsui S; Teramukai S; Tomita N; Sugihara K;
J Clin Oncol; 2019 Aug; 37(22):1886-1894. PubMed ID: 31180819
[TBL] [Abstract][Full Text] [Related]
5. Disentangling the prognostic heterogeneity of stage III colorectal cancer through histologic stromal categorization.
Ueno H; Sekine S; Oshiro T; Kanemitsu Y; Hamaguchi T; Shida D; Takashima A; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Mochizuki S; Kajiwara Y; Shinto E; Yamamoto J; Shimada Y
Surgery; 2018 Apr; 163(4):777-783. PubMed ID: 29162344
[TBL] [Abstract][Full Text] [Related]
6. Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence-free survival in stages I-III colorectal cancer.
González IA; Bauer PS; Liu J; Chatterjee D
Histopathology; 2021 Jan; 78(2):252-264. PubMed ID: 32654226
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of histological categorization of desmoplastic reaction in colorectal liver metastases.
Ao T; Kajiwara Y; Yonemura K; Shinto E; Mochizuki S; Okamoto K; Aosasa S; Ueno H
Virchows Arch; 2019 Sep; 475(3):341-348. PubMed ID: 31076902
[TBL] [Abstract][Full Text] [Related]
8. Morphological consistency of desmoplastic reactions between the primary colorectal cancer lesion and associated metastatic lesions.
Ao T; Kajiwara Y; Yonemura K; Shinto E; Mochizuki S; Okamoto K; Kishi Y; Ueno H
Virchows Arch; 2020 Jul; 477(1):47-55. PubMed ID: 31932918
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of desmoplastic stromal reaction, tumor budding and tumor-stroma ratio in stage II colorectal cancer.
Fan S; Cui X; Zheng L; Ma W; Zheng S; Wang J; Qi L; Ye Z
J Gastrointest Oncol; 2022 Dec; 13(6):2903-2921. PubMed ID: 36636094
[TBL] [Abstract][Full Text] [Related]
10. Histologic categorization of desmoplastic reaction: its relevance to the colorectal cancer microenvironment and prognosis.
Ueno H; Shinto E; Shimazaki H; Kajiwara Y; Sueyama T; Yamamoto J; Hase K
Ann Surg Oncol; 2015 May; 22(5):1504-12. PubMed ID: 25395146
[TBL] [Abstract][Full Text] [Related]
11. Optimal Criteria for G3 (Poorly Differentiated) Stage II Colon Cancer: Prospective Validation in a Randomized Controlled Study (SACURA Trial).
Ueno H; Ishiguro M; Nakatani E; Ishikawa T; Uetake H; Matsui S; Teramukai S; Murotani K; Ajioka Y; Shimazaki H; Maeda A; Takuma K; Yoshida T; Kambara T; Matsuda K; Takagane A; Tomita N; Sugihara K;
Am J Surg Pathol; 2020 Dec; 44(12):1685-1698. PubMed ID: 32868525
[TBL] [Abstract][Full Text] [Related]
12. Histological categorisation of the desmoplastic reaction is a predictor of patient prognosis in oesophageal squamous cell carcinoma.
Sakai A; Nakashima Y; Miyashita Y; Ao T; Kimura Y; Shinto E; Oki E; Shimokawa M; Ueno H; Oda Y; Mori M
Histopathology; 2021 Aug; 79(2):219-226. PubMed ID: 33595141
[TBL] [Abstract][Full Text] [Related]
13. Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer.
Okuyama T; Sameshima S; Takeshita E; Mitsui T; Noro T; Ono Y; Noie T; Ban S; Oya M
BMC Cancer; 2020 Sep; 20(1):842. PubMed ID: 32883261
[TBL] [Abstract][Full Text] [Related]
14. Desmoplastic Reaction Associates with Prognosis and Adjuvant Chemotherapy Response in Colorectal Cancer: A Multicenter Retrospective Study.
Hu Q; Wang Y; Yao S; Mao Y; Liu L; Li Z; Chen Y; Zhang S; Li Q; Zhao Y; Fan X; Cui Y; Zhao K; Liu Z
Cancer Res Commun; 2023 Jun; 3(6):1057-1066. PubMed ID: 37377615
[TBL] [Abstract][Full Text] [Related]
15. Pathological classification of desmoplastic reaction is prognostic factor in cervical adenocarcinoma.
Akimoto T; Takasawa A; Takasawa K; Aoyama T; Matsuura M; Tamate M; Iwasaki M; Habata S; Murakami T; Osanai M; Saito T
Med Mol Morphol; 2022 Dec; 55(4):275-282. PubMed ID: 35876908
[TBL] [Abstract][Full Text] [Related]
16. Histologic categorization of fibrotic cancer stroma in the primary tumor is an independent prognostic index in resectable colorectal liver metastasis.
Ueno H; Konishi T; Ishikawa Y; Shimazaki H; Ueno M; Aosasa S; Saiura A; Hase K; Yamamoto J
Am J Surg Pathol; 2014 Oct; 38(10):1380-6. PubMed ID: 24832160
[TBL] [Abstract][Full Text] [Related]
17. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
Matsuda C; Ishiguro M; Teramukai S; Kajiwara Y; Fujii S; Kinugasa Y; Nakamoto Y; Kotake M; Sakamoto Y; Kurachi K; Maeda A; Komori K; Tomita N; Shimada Y; Takahashi K; Kotake K; Watanabe M; Mochizuki H; Nakagawa Y; Sugihara K;
Eur J Cancer; 2018 Jun; 96():54-63. PubMed ID: 29677641
[TBL] [Abstract][Full Text] [Related]
18. Inferior oncological prognosis of surgery without oral chemotherapy for stage III colon cancer in clinical settings.
Tashiro J; Yamaguchi S; Ishii T; Suzuki A; Kondo H; Morita Y; Hara K; Koyama I
World J Surg Oncol; 2014 May; 12():145. PubMed ID: 24884880
[TBL] [Abstract][Full Text] [Related]
19. Immature Stroma and Prognostic Profiling in Colorectal Carcinoma: Development and Validation of Novel Classification Systems.
Hacking S; Ebare K; Angert M; Lee L; Vitkovski T; Thomas R; Chavarria H; Jin C; Nasim M
Pathol Res Pract; 2020 Jul; 216(7):152970. PubMed ID: 32534718
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
